{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:01:59Z","timestamp":1791943319537,"version":"4.3.4"},"reference-count":68,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"American University","award":["7R15AI172610-02"],"award-info":[{"award-number":["7R15AI172610-02"]}]},{"name":"American University","award":["P30AI117970"],"award-info":[{"award-number":["P30AI117970"]}]},{"name":"National Institutes of Health (NIH)","award":["7R15AI172610-02"],"award-info":[{"award-number":["7R15AI172610-02"]}]},{"name":"National Institutes of Health (NIH)","award":["P30AI117970"],"award-info":[{"award-number":["P30AI117970"]}]},{"name":"District of Columbia Center for AIDS Research (DC-CFAR)","award":["7R15AI172610-02"],"award-info":[{"award-number":["7R15AI172610-02"]}]},{"name":"District of Columbia Center for AIDS Research (DC-CFAR)","award":["P30AI117970"],"award-info":[{"award-number":["P30AI117970"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The \u201cKick and Kill\u201d strategy, which aims to reactivate latent HIV reservoirs and facilitate the clearance of reactivated HIV-infected cells, has yet to achieve a functional cure due to the limited efficacy of current latency reversal agents. This study evaluates the combination efficacy of histone deacetylase (HDAC) inhibitor with poly(ADP-ribose) polymerase (PARP) inhibitor in latency reversal and immune-mediated clearance. Latently infected J-Lat cells and dual-fluorescent HIV-infected primary CD4 T cells were treated with the HDAC inhibitor (vorinostat) and one of four PARP inhibitors (olaparib, rucaparib, niraparib, or talazoparib). PARP inhibitors, when administered alone, showed no latency reversal activity. However, when combined with vorinostat, their efficacy increased threefold compared to vorinostat alone. This effect was mediated by the inhibition of tankyrase, a PARP superfamily member, which modulates the Hippo signaling pathway. In HIVGR670-infected primary cells, the combination reduced the reservoir size by 67%. In addition, talazoparib alone significantly reduced actively infected cells by 50%. Talazoparib-treated peripheral blood mononuclear cells co-cultured with K562 cells demonstrated enhanced NK-cell-mediated cytotoxicity, with a 10% reduction in K562 cell viability. These findings demonstrate that combining HDAC and PARP inhibitors augments latency reversal and reservoir reduction. With both the HDAC inhibitors and PARP inhibitors used in this study approved by the FDA for cancer treatment, this combination therapy holds strong potential for rapid clinical integration, contingent upon the confirmation of efficacy and safety in ongoing in vivo studies.<\/jats:p>","DOI":"10.3390\/v17030400","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T04:55:44Z","timestamp":1741755344000},"page":"400","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Targeting Latent HIV Reservoirs: Effectiveness of Combination Therapy with HDAC and PARP Inhibitors"],"prefix":"10.3390","volume":"17","author":[{"given":"Hasset","family":"Tibebe","sequence":"first","affiliation":[{"name":"Department of Biology, College of Arts & Sciences, American University, Washington, DC 20016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dacia","family":"Marquez","sequence":"additional","affiliation":[{"name":"Department of Biology, College of Arts & Sciences, American University, Washington, DC 20016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9272-0805","authenticated-orcid":false,"given":"Aidan","family":"McGraw","sequence":"additional","affiliation":[{"name":"Department of Biology, College of Arts & Sciences, American University, Washington, DC 20016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Gagliardi","sequence":"additional","affiliation":[{"name":"Department of Biology, College of Arts & Sciences, American University, Washington, DC 20016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cailyn","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Department of Biology, College of Arts & Sciences, American University, Washington, DC 20016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Hillmer","sequence":"additional","affiliation":[{"name":"Department of Biology, College of Arts & Sciences, American University, Washington, DC 20016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kedhar","family":"Narayan","sequence":"additional","affiliation":[{"name":"Department of Biology, College of Arts & Sciences, American University, Washington, DC 20016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8581-0474","authenticated-orcid":false,"given":"Coco","family":"Izumi","sequence":"additional","affiliation":[{"name":"Department of Biology, College of Arts & Sciences, American University, Washington, DC 20016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adleigh","family":"Keating","sequence":"additional","affiliation":[{"name":"Department of Biology, College of Arts & Sciences, American University, Washington, DC 20016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8193-0813","authenticated-orcid":false,"given":"Taisuke","family":"Izumi","sequence":"additional","affiliation":[{"name":"Department of Biology, College of Arts & Sciences, American University, Washington, DC 20016, USA"},{"name":"District of Columbia Center for AIDS Research, Washington, DC 20052, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1038\/s41591-024-03277-z","article-title":"Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells","volume":"30","author":"Mamez","year":"2024","journal-title":"Nat. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41591-023-02213-x","article-title":"In-depth virological and immunological characterization of HIV-1 cure after CCR5Delta32\/Delta32 allogeneic hematopoietic stem cell transplantation","volume":"29","author":"Jensen","year":"2023","journal-title":"Nat. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"105680","DOI":"10.1016\/j.meegid.2024.105680","article-title":"Unveiling ancestral threads: Exploring CCR5 \u220632 mutation frequencies in Colombian populations for HIV\/AIDS therapeutics","volume":"125","author":"Nguyen","year":"2024","journal-title":"Infect. Genet. Evol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"McGraw, A., Hillmer, G., Choi, J., Narayan, K., Mehedincu, S.M., Marquez, D., Tibebe, H., DeCicco-Skinner, K.L., and Izumi, T. (2024). Evaluating HIV-1 Infectivity and Virion Maturation across Varied Producer Cells with a Novel FRET-Based Detection and Quantification Assay. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25126396"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Sarca, A.D., Sardo, L., Fukuda, H., Matsui, H., Shirakawa, K., Horikawa, K., Takaori-Kondo, A., and Izumi, T. (2021). FRET-Based Detection and Quantification of HIV-1 Virion Maturation. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.647452"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"McGraw, A., Hillmer, G., Medehincu, S.M., Hikichi, Y., Gagliardi, S., Narayan, K., Tibebe, H., Marquez, D., Mei Bose, L., and Keating, A. (2024). Exploring HIV-1 Maturation: A New Frontier in Antiviral Development. Viruses, 16.","DOI":"10.3390\/v16091423"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Ta, T.M., Malik, S., Anderson, E.M., Jones, A.D., Perchik, J., Freylikh, M., Sardo, L., Klase, Z.A., and Izumi, T. (2022). Insights Into Persistent HIV-1 Infection and Functional Cure: Novel Capabilities and Strategies. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.862270"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Sardo, L., Parolin, C., Yoshida, T., Garzino-Demo, A., and Izumi, T. (2021). Editorial: Novel Insights Into a Functional HIV Cure. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.797570"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Thorlund, K., Horwitz, M.S., Fife, B.T., Lester, R., and Cameron, D.W. (2017). Landscape review of current HIV \u2018kick and kill\u2019 cure research\u2014some kicking, not enough killing. BMC Infect. Dis., 17.","DOI":"10.1186\/s12879-017-2683-3"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Perdigao, P., Gaj, T., Santa-Marta, M., Barbas, C.F., and Goncalves, J. (2016). Reactivation of Latent HIV-1 Expression by Engineered TALE Transcription Factors. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0150037"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"F1000 Faculty Rev-1009","DOI":"10.12688\/f1000research.8109.1","article-title":"Targeting the latent reservoir to achieve functional HIV cure","volume":"5","author":"Cary","year":"2016","journal-title":"F1000Research"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.1255512","article-title":"Immunologic strategies for HIV-1 remission and eradication","volume":"345","author":"Barouch","year":"2014","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/aid.2014.0235","article-title":"Exploring the potential of monoclonal antibody therapeutics for HIV-1 eradication","volume":"31","author":"Euler","year":"2015","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1016\/S2352-3018(16)30055-8","article-title":"Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): A single-arm, phase 1B\/2A trial","volume":"3","author":"Leth","year":"2016","journal-title":"Lancet HIV"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"100342","DOI":"10.1016\/j.jve.2023.100342","article-title":"The efficacy and tolerability of latency-reversing agents in reactivating the HIV-1 reservoir in clinical studies: A systematic review","volume":"9","author":"Debrabander","year":"2023","journal-title":"J. Virus Erad."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1189\/jlb.0711339","article-title":"Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression","volume":"91","author":"Rossi","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Jones, R.B., O\u2019Connor, R., Mueller, S., Foley, M., Szeto, G.L., Karel, D., Lichterfeld, M., Kovacs, C., Ostrowski, M.A., and Trocha, A. (2014). Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytes. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004287"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/infdis\/jiv022","article-title":"Expanded cytotoxic T-cell lymphocytes target the latent HIV reservoir","volume":"212","author":"Sung","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.febslet.2007.02.045","article-title":"Histone deacetylase inhibitors suppress natural killer cell cytolytic activity","volume":"581","author":"Ogbomo","year":"2007","journal-title":"FEBS Lett."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1128\/JVI.05545-11","article-title":"The histone deacetylase inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells by inhibition of STAT5\/T-BET signaling and generation of gamma interferon","volume":"86","author":"Yu","year":"2012","journal-title":"J. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.tibs.2009.12.003","article-title":"Toward a unified nomenclature for mammalian ADP-ribosyltransferases","volume":"35","author":"Hottiger","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1111\/febs.14078","article-title":"ADP-ribosylation: New facets of an ancient modification","volume":"284","author":"Palazzo","year":"2017","journal-title":"FEBS J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.celrep.2015.09.014","article-title":"Tankyrase Inhibitors Target YAP by Stabilizing Angiomotin Family Proteins","volume":"13","author":"Wang","year":"2015","journal-title":"Cell Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/nature08356","article-title":"Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling","volume":"461","author":"Huang","year":"2009","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/ncb3216","article-title":"Genome-wide association between YAP\/TAZ\/TEAD and AP-1 at enhancers drives oncogenic growth","volume":"17","author":"Zanconato","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-018-0658-1","article-title":"The SWI\/SNF complex is a mechanoregulated inhibitor of YAP and TAZ","volume":"563","author":"Chang","year":"2018","journal-title":"Nature"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/s41591-018-0158-8","article-title":"Transcriptional addiction in cancer cells is mediated by YAP\/TAZ through BRD4","volume":"24","author":"Zanconato","year":"2018","journal-title":"Nat. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0168-9525(97)01093-7","article-title":"WNTs modulate cell fate and behavior during vertebrate development","volume":"13","author":"Moon","year":"1997","journal-title":"Trends Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1101\/gad.10.20.2527","article-title":"Signal transduction through beta-catenin and specification of cell fate during embryogenesis","volume":"10","author":"Miller","year":"1996","journal-title":"Genes. Dev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jve.2024.100458","article-title":"PP1. 9\u201300102 Targeting Latent HIV Reservoirs: Effectiveness of Combination Therapy with HDAC and PARP Inhibitors","volume":"10","author":"McGraw","year":"2024","journal-title":"J. Virus Erad."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e34655","DOI":"10.7554\/eLife.34655","article-title":"Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4(+) T cells","volume":"7","author":"Battivelli","year":"2018","journal-title":"Elife"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41467-018-08050-8","article-title":"Smallest near-infrared fluorescent protein evolved from cyanobacteriochrome as versatile tag for spectral multiplexing","volume":"10","author":"Oliinyk","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.chembiol.2017.05.018","article-title":"How to Increase Brightness of Near-Infrared Fluorescent Proteins in Mammalian Cells","volume":"24","author":"Shemetov","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Barbian, H.J., Seaton, M.S., Narasipura, S.D., Wallace, J., Rajan, R., Sha, B.E., and Al-Harthi, L. (2022). beta-catenin regulates HIV latency and modulates HIV reactivation. PLoS Pathog., 18.","DOI":"10.1371\/journal.ppat.1010354"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.joca.2017.08.015","article-title":"A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee","volume":"26","author":"Deshmukh","year":"2018","journal-title":"Osteoarthr. Cartil."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"25390","DOI":"10.18632\/oncotarget.4455","article-title":"Tankyrase inhibitors attenuate WNT\/beta-catenin signaling and inhibit growth of hepatocellular carcinoma cells","volume":"6","author":"Ma","year":"2015","journal-title":"Oncotarget"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Sarabia, I., Novis, C.L., Macedo, A.B., Takata, H., Nell, R., Kakazu, J.C., Furler, R.L., Shakya, B., Schubert, H.L., and Hill, C.P. (2021). Activation of the Anti-Oxidative Stress Response Reactivates Latent HIV-1 Through the Mitochondrial Antiviral Signaling Protein Isoform MiniMAVS. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.682182"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1021\/acs.jmedchem.6b00990","article-title":"Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors","volume":"60","author":"Thorsell","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e00719-19","DOI":"10.1128\/JVI.00719-19","article-title":"Primary HIV-1 Strains Use Nef To Downmodulate HLA-E Surface Expression","volume":"93","author":"Akko","year":"2019","journal-title":"J. Virol."},{"key":"ref_40","first-page":"56191","article-title":"A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity","volume":"126","author":"Kandarian","year":"2017","journal-title":"J. Vis. Exp."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Rose, M., Burgess, J.T., O\u2019Byrne, K., Richard, D.J., and Bolderson, E. (2020). PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.564601"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41392-023-01548-8","article-title":"A new wave of innovations within the DNA damage response","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.4161\/cc.10.8.15273","article-title":"Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations","volume":"10","author":"Dedes","year":"2011","journal-title":"Cell Cycle"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: Synthetic lethality in the clinic","volume":"355","author":"Lord","year":"2017","journal-title":"Science"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e103479","DOI":"10.15252\/embj.2019103479","article-title":"To PARP or not to PARP?-Toward sensitizing acute myeloid leukemia stem cells to immunotherapy","volume":"38","author":"Heyman","year":"2019","journal-title":"EMBO J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13045-022-01228-0","article-title":"Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies","volume":"15","author":"Padella","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41586-019-1410-1","article-title":"Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion","volume":"572","author":"Paczulla","year":"2019","journal-title":"Nature"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/cmi.2017.161","article-title":"Functions of NKG2D in CD8(+) T cells: An opportunity for immunotherapy","volume":"15","author":"Prajapati","year":"2018","journal-title":"Cell Mol. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Franzese, O., and Graziani, G. (2022). Role of PARP Inhibitors in Cancer Immunotherapy: Potential Friends to Immune Activating Molecules and Foes to Immune Checkpoints. Cancers, 14.","DOI":"10.3390\/cancers14225633"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Fan, Z., Han, D., Fan, X., and Zhao, L. (2023). Ovarian cancer treatment and natural killer cell-based immunotherapy. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1308143"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1101\/gad.2000111","article-title":"Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein","volume":"25","author":"Zhao","year":"2011","journal-title":"Genes. Dev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41418-021-00849-1","article-title":"The Hippo signaling component LATS2 enhances innate immunity to inhibit HIV-1 infection through PQBP1-cGAS pathway","volume":"29","author":"He","year":"2022","journal-title":"Cell Death Differ."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.molcel.2017.07.025","article-title":"The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI\/SNF Chromatin-Remodeling Complexes","volume":"67","author":"Conrad","year":"2017","journal-title":"Mol. Cell"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/nar\/gks976","article-title":"The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation","volume":"41","author":"Li","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.celrep.2012.09.008","article-title":"Reactivation of latent HIV-1 by inhibition of BRD4","volume":"2","author":"Zhu","year":"2012","journal-title":"Cell Rep."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Li, Z., Mbonye, U., Feng, Z., Wang, X., Gao, X., Karn, J., and Zhou, Q. (2018). The KAT5-Acetyl-Histone4-Brd4 axis silences HIV-1 transcription and promotes viral latency. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1007012"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Callow, M.G., Tran, H., Phu, L., Lau, T., Lee, J., Sandoval, W.N., Liu, P.S., Bheddah, S., Tao, J., and Lill, J.R. (2011). Ubiquitin ligase RNF146 regulates tankyrase and Axin to promote Wnt signaling. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0022595"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/ncb2222","article-title":"RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling","volume":"13","author":"Zhang","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Silva-Garcia, O., Valdez-Alarcon, J.J., and Baizabal-Aguirre, V.M. (2019). Wnt\/beta-Catenin Signaling as a Molecular Target by Pathogenic Bacteria. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02135"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1073\/pnas.1414167112","article-title":"beta-Catenin in dendritic cells exerts opposite functions in cross-priming and maintenance of CD8+ T cells through regulation of IL-10","volume":"112","author":"Fu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1158\/1078-0432.CCR-10-0356","article-title":"Wnt\/beta-catenin signaling in T-cell immunity and cancer immunotherapy","volume":"16","author":"Gattinoni","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_62","first-page":"303","article-title":"Wnt signaling in dendritic cells: Its role in regulation of immunity and tolerance","volume":"19","author":"Swafford","year":"2015","journal-title":"Discov. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40425-015-0089-6","article-title":"A new paradigm for tumor immune escape: Beta-catenin-driven immune exclusion","volume":"3","author":"Spranger","year":"2015","journal-title":"J. Immunother. Cancer"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.4049\/jimmunol.176.3.1439","article-title":"Human naive CD8 T cells down-regulate expression of the WNT pathway transcription factors lymphoid enhancer binding factor 1 and transcription factor 7 (T cell factor-1) following antigen encounter in vitro and in vivo","volume":"176","author":"Willinger","year":"2006","journal-title":"J. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nm.1982","article-title":"Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells","volume":"15","author":"Gattinoni","year":"2009","journal-title":"Nat. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e01094-19","DOI":"10.1128\/JVI.01094-19","article-title":"Pharmacological Modulation of the Wnt\/beta-Catenin Pathway Inhibits Proliferation and Promotes Differentiation of Long-Lived Memory CD4(+) T Cells in Antiretroviral Therapy-Suppressed Simian Immunodeficiency Virus-Infected Macaques","volume":"94","author":"Mavigner","year":"2019","journal-title":"J. Virol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/ni.1762","article-title":"T cell factor 1 initiates the T helper type 2 fate by inducing the transcription factor GATA-3 and repressing interferon-gamma","volume":"10","author":"Yu","year":"2009","journal-title":"Nat. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Zou, M., Al-Yahya, S., Al-Alwan, M., BinEssa, H.A., Khabar, K.S.A., Almohanna, F., Assiri, A.M., Altaweel, A., Qattan, A., and Meyer, B.F. (2023). beta-catenin attenuation leads to up-regulation of activating NKG2D ligands and tumor regression in Braf(V600E)-driven thyroid cancer cells. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1171816"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/3\/400\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:51:01Z","timestamp":1760028661000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/3\/400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":68,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["v17030400"],"URL":"https:\/\/doi.org\/10.3390\/v17030400","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]}}}